Schonfeld Strategic Advisors LLC Ligand Pharmaceuticals Inc Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $626,065 - $813,593	9,121 New	9,121 $666,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $31 - $337,308	3,136 New	3,136 $270,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $174,397 - $242,963	-2,022 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $217,122 - $261,525	2,022 New	2,022 $231,000
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $1.06 Million - $1.42 Million	-10,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $898,520 - $1.9 Million	7,000 Added 233.33%	10,000 $1.36 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $633,540 - $823,470	3,000 New	3,000 $823,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.